Levi & Korsinsky Notifies Bitfarms Ltd. (BITF) Shareholders of Class Action Lawsuit and July 8, 2025 Deadline — Neutral
BITF Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=151888&wire=1&utm_campaign=15 or contact Joseph E.

Lost Money on Compass Group Diversified Holdings, LLC (CODI)? Urged to Join Class Action Before July 8, 2025 - Contact Levi & Korsinsky — Neutral
CODI Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151891&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Krispy Kreme, Inc. (DNUT) Shareholders of Class Action Lawsuit and July 15, 2025 Deadline — Neutral
DNUT Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151887&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Shareholders of Class Action Lawsuit and June 10, 2025 Deadline — Neutral
TMCI Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151894&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Class Action Filed Against Red Cat Holdings, Inc. (RCAT) Over Securities Violations - Contact Levi & Korsinsky Today — Neutral
RCAT Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=151893&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

UroGen Pharma Ltd. (URGN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 28, 2025 Deadline — Neutral
URGN Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151892&wire=1&utm_campaign=1 or contact Joseph E.

Zenas BioPharma, Inc. (ZBIO) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 16, 2025 Deadline — Neutral
ZBIO Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151890&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

Contact Levi & Korsinsky by July 14, 2025 to Join Class Action Against Iovance Biotherapeutics, Inc. (IOVA) — Neutral
IOVA Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151889&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

June 24, 2025 Deadline: Join Class Action Lawsuit Against Avis Budget Group, Inc. (CAR) - Contact Levi & Korsinsky — Neutral
CAR Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=151898&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

Ibotta, Inc. (IBTA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 16, 2025 Deadline — Neutral
IBTA Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151897&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

June 10, 2025 Deadline: Join Class Action Lawsuit Against BigBear.ai Holdings, Inc. (BBAI) - Contact Levi & Korsinsky — Neutral
BBAI Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=151896&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

Investors Urged to Contact Levi & Korsinsky for Information Before June 30, 2025 - Open Lending Corporation (LPRO) — Neutral
LPRO Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151895&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.

Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky — Neutral
WST Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151886&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

Class Action Lawsuit Filed Against Digimarc Corporation (DMRC) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025 — Neutral
DMRC Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=151885&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

Investors in Fortrea Holdings Inc. (FTRE): Protect Your Rights - Contact Levi & Korsinsky Before August 1, 2025 — Neutral
FTRE Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=151884&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities — Neutral
ARAY PRNewsWire — June 06, 2025MADISON, Wis. , June 6, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2026 (the "Notes") to exchange an aggregate of $82.0 million principal amount of Notes for an aggregate of 8,881,579 shares of the Accuray's common stock (the "Shares").

Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million — Neutral
VERO GlobeNewsWire — June 06, 2025TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement to sell its Venus Hair business to MHG Co. Ltd (“Meta Healthcare Group”) in an all-cash transaction valued at $20 million, subject to a customary working capital adjustment. The net proceeds from the transaction, once completed, will enhance the Company's balance sheet and financial condition and provide valuable capital to fund strategic growth initiatives.

Sun Belt State Transportation Agency to Deploy 150 Rekor Discover® Systems Under Rekor's Data-as-a-Service Model — Neutral
REKR GlobeNewsWire — June 06, 2025Rekor Discover® to Replace Outdated Roadway Intrusive Technology with FHWA-Compliant AI That Advances Transportation Planning and Operations Rekor Discover® to Replace Outdated Roadway Intrusive Technology with FHWA-Compliant AI That Advances Transportation Planning and Operations

Shareholders That Lost Money on Cytokinetics, Incorporated(CYTK) Should Contact Levi & Korsinsky about Securities Fraud Investigation - CYTK — Neutral
CYTK Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has delayed an approval decision on Cytokinetics' experimental hypertrophic obstructive cardiomyopathy drug aficamten so it can have more time to review the company's proposed risk management plan.

Vestis Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - VSTS — Neutral
VSTS Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vestis Corporation ("Vestis Corporation") (NYSE:VSTS) concerning possible violations of federal securities laws. On May 6, 2025, Vestis reported a significant drop in 2Q 2025 revenue results that missed analysts' expectations.
